Sure. Happy to, Matt. So yeah, the credit story, obviously, at the headline here looks negative because we had negative risk rating migration. But it really was sort of unique to a couple of discrete portfolios mainly in the office portfolio in CRE, which, as you know, is $950 million. Our NPLs in commercial went up $84 million, I believe, and that was the result almost entirely of four office loans. So you get a sense again of the granularity, not huge single point exposures and so the rest of the entire loan portfolio sort of behaved as you would normally kind of slowly migrating to normalized credit. With respect to loss content, it's awful hard. I mean what I would tell you is when we're looking at NPLs, obviously, we do a deep dive, we get updated appraisals. And so all of that is kind of factored into CECL. And so what I would say is in our 130 coverage ratio, we believe that, obviously, we have adequate reserves for any expected losses. I'd also tell you, and it wasn't just a throwaway comment that 3/4 of our office loans have some sort of credit enhancement, which doesn't really factor into the probability of default risk rating, but factors in our minds into loss given default. So things like debt service reserves, additional completion guarantees, extended guarantees from the sponsor and maybe bootstrap collateral from other property types, we think all will help mitigate losses. So again, we don't see loss content really impacting. We still look at our projected annualized charge-off rate in that 25 basis point to 30 basis point range. Obviously, as we always qualify, we say that in commercial lending, you can have a bigger quarter and a smaller quarter, but kind of as a run rate, we still think our losses are not going to change as we move forward. We're well reserved. And again, we're encouraged by the fact that everything you see from a credit perspective really in this quarter is a result of what happened in our office portfolio, and a bit in C&I, and I'll just anticipate the next question in kind of our health care related and health care services portfolio, which is also under $1 billion. But as you probably know, industry-wide, that's been a little bit challenged for things like labor availability, wage inflation, higher input costs and slower reimbursement rates. So again, we're encouraged by the fact that it's not a portfolio wide deterioration, but really into discrete portfolios that are relatively small, and we think we have a good handle on.